Bio-Rad Labs (BIO) to Acquire Stilla Technologies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Strong earthquake rocks north-central Venezuela, capital Caracas
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Bio-Rad Labs (BIO) PT Lowered to $400 at Citi
February 14, 2025 9:19 AM ESTCiti analyst Patrick Donnelly lowered the price target on Bio-Rad Labs (NYSE: BIO) to $400.00 (from $450.00) while maintaining a Buy rating.
The analyst comments "BIO guided core FY25 to grow +1.5-3.5% vs. consensus of +2.5%, with Life Sci at +1.5-3.5% vs. Dx at +2-3%. GM /... More
